The overall objective of this project is to assess whether Silymarin therapy shortens illness
or prevents complications in patients with acute hepatitis. We will specifically compare
responses in acute hepatitis patients treated with Silymarin to those given a control
preparation of a vitamin supplements in a double blinded, randomized, placebo-controlled
trial.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore